Advisory boards are key in helping pharmaceutical manufacturers refine product positioning and guide value messaging throughout the product life cycle. Like many processes this year, advisory boards have been impacted by the pandemic’s travel restrictions and have been unable to convene as traditional in-person meetings, but the need for their thought leadership remains.
As manufacturers adapt, leaders might feel limited to multiple one-on-one discussions with board members or be struggling with the number of challenges associated with virtual meetings:
- Disengaging, disjointed board conversations via video
- Absence of hands-on tools, such as illustrating concepts on whiteboards
- Lack of creativity and ingenuity
As board meetings continue to be held virtually, EVERSANA is helping our partners leverage this option more efficiently to meet the demands of today’s hybrid world. Read more from our global commercialization experts about how to create engagement and cultivate creativity for your advisory board.
EVERSANA employs a team of over 2500 professionals across 27 locations around the world. From industry-leading patient service and adherence support to global pricing and revenue management, our team informs the strategies that matter…